1. Home
  2. LOOP vs CGTX Comparison

LOOP vs CGTX Comparison

Compare LOOP & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$1.02

Market Cap

58.1M

Sector

Industrials

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.47

Market Cap

132.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
CGTX
Founded
2010
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
132.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LOOP
CGTX
Price
$1.02
$1.47
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.33
AVG Volume (30 Days)
73.4K
896.2K
Earning Date
01-15-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,112,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$41.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10901.98
N/A
52 Week Low
$0.85
$0.22
52 Week High
$2.29
$3.83

Technical Indicators

Market Signals
Indicator
LOOP
CGTX
Relative Strength Index (RSI) 46.32 46.72
Support Level $0.95 $1.33
Resistance Level $1.04 $1.62
Average True Range (ATR) 0.06 0.11
MACD 0.02 -0.02
Stochastic Oscillator 69.08 32.56

Price Performance

Historical Comparison
LOOP
CGTX

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: